Allele Diagnostics

Allele Diagnostics

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Allele Diagnostics, founded in 2014 and based in Spokane, WA, is a private, revenue-generating diagnostics services company. It provides essential cytogenetic and microarray testing primarily for prenatal, pediatric, and neonatal care, differentiating itself through a focus on speed, accuracy, and client collaboration. The company is led by an experienced CEO with a strong background in life sciences business management and operates with a client-centric model that includes genetic counseling support.

Reproductive HealthPediatricsNeonatology

Technology Platform

Established cytogenetic and molecular cytogenetic technologies including chromosomal microarray (CMA/array CGH), karyotyping, and fluorescence in situ hybridization (FISH), with a focus on operational optimization and continuous evaluation of novel methods.

Opportunities

Growing demand for rapid, confirmatory diagnostic testing in prenatal and pediatric care creates a steady market.
The company can leverage its service-oriented model and genetic counseling support to differentiate from larger, impersonal labs and build strong, loyal client relationships in niche segments.

Risk Factors

Faces significant reimbursement pressure and regulatory compliance burdens common to diagnostic labs.
Its core microarray technology risks disruption by next-generation sequencing methods, and it operates in a highly competitive market dominated by large players with greater scale and resources.

Competitive Landscape

Competes against large national reference labs (LabCorp, Quest Diagnostics), specialized genetic testing companies, and hospital-based labs. Its differentiation is based on personalized service, fast turnaround times, and integrated genetic counseling, rather than competing on price or breadth of test menu alone.